Several studies have shown that the inhibitor of the NLRP3 inflammasome (MCC950) can effectively reverse the motor deficits in ALS-containing GA-DPR-expressing mice caused by the activation of the NLRP3 inflammasome [54]. Here, NLRP3 is linked to amyotrophic lateral sclerosis.